0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Clinical Challenge | 
Lawrence Wong, MD; Shoji Yano, MD, PhD
JAMA. 2012;308(6):617-618. doi:10.1001/jama.2012.8136.

Health Agencies Update | 
Bridget M. Kuehn
JAMA. 2008;299(24):2847. doi:10.1001/jama.299.24.2847-b.

Capitol Health Call | 
Mike Mitka
JAMA. 2007;298(14):1631. doi:10.1001/jama.298.14.1631-b.

From the Centers for Disease Control and Prevention |  FREE
JAMA. 2001;285(2):157-158. doi:10.1001/jama.285.2.157.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Facial Plastic Surgery
Review  | 
A Review of Medical and Surgical Treatment Options for Androgenetic Alopecia
Daniel E. Rousso, MD; Sang W. Kim, MD
JAMA Dermatology
Original Investigation  | 
Diagnostic Usefulness of a Peribulbar Eosinophilic Infiltrate in Alopecia Areata
Tae Young Yoon, MD, PhD; Dong Yoon Lee, MD; Young Jin Kim, MD; et al.
JAMA Dermatology
Observation  | 
Development of Trichodysplasia Spinulosa:  Case Report of a Patient With Gorlin Syndrome Treated With Vismodegib
Justin D. Richey, MD; Thomas A. Graham, MD, PhD; Terrence Katona, DO; et al.
JAMA Ophthalmology
Ophthalmic Images  | 
Acquired Trichomegaly:  Trichomegaly Secondary to Erlotinib
Carlos A. Medina Mendez, MD; Patrick C. Ma, MD; Arun D. Singh, MD